Effects of Gekko sulfated polysaccharide on the proliferation and differentiation of hepatic cancer cell line

被引:63
作者
Wu, XiongZhi [1 ]
Chen, Dan [1 ]
Xie, Guang-Ru [1 ]
机构
[1] Tianjin Med Univ, Canc Ctr Integrated Trad & Western Med, Canc Hosp Tianjin, Tianjin 300060, Hexi District, Peoples R China
关键词
Gekko; sulfated polysaccharide; hepatocarcinoma; differentiation; proliferation;
D O I
10.1016/j.cellbi.2006.04.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Gekko swinhonis Guenther has been used as an anti-cancer drug in traditional Chinese medicine. Gekko sulfated polysaccharide (Gepsin) was investigated for its activity in hepatocellular carcinoma. Hepatocarcinoma cell line (Bel-7402) and liver cell line (L-02) were exposed to Gepsin (100 mu g/ml and 10 mu g/ml). Gepsin did not suppress the proliferation and viability of normal liver L-02 cells, but strongly inhibited the proliferation of hepatocarcinoma Bel-7402 cells. Gepsin did not induce the apoptosis of Bel-7402 cells, but blocked cells in G(2)/M phase. Treated with Gepsin, Bel-7402 cells showed ultrastructural features of differentiation. AFP secretion decreased while ALB secretion increased markedly on Gepsin-treated cells. The data show that Gepsin suppressed the proliferation and induced differentiation of hepatocarcinoma, but the toxicity to normal liver cells was negligible. (c) 2006 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 25 条
[1]   Fucoidan induces apoptosis of human HS-Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways [J].
Aisa, Y ;
Miyakawa, Y ;
Nakazato, T ;
Shibata, H ;
Saito, K ;
Ikeda, Y ;
Kizaki, M .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (01) :7-14
[2]   GROWTH-INHIBITION IN-VITRO OF MURINE MAMMARY ADENOCARCINOMA CELLS BY HEPARIN AND CHEMICALLY-MODIFIED HEPARINS [J].
BERTOLESI, GE ;
DECIDRE, LL ;
EIJAN, AM .
TUMOR BIOLOGY, 1994, 15 (05) :275-283
[3]   EFFECTS IN-VITRO OF SULFATED POLYSACCHARIDE FROM SCHIZYMENIA-DUBYI (RHODOPHYTA, GIGARTINALES) ON A NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA LINE (NSCLC-N6) [J].
BOURGOUGNON, N ;
ROUSSAKIS, C ;
KORNPROBST, JM ;
LAHAYE, M .
CANCER LETTERS, 1994, 85 (01) :87-92
[4]  
Chedid A, 1999, ARCH PATHOL LAB MED, V123, P524
[5]   A NOTE ON DETERMINATION OF ESTER SULPHATE CONTENT OF SULPHATED POLYSACCHARIDES [J].
DODGSON, KS ;
PRICE, RG .
BIOCHEMICAL JOURNAL, 1962, 84 (01) :106-&
[6]   Cyclin proteolysis as a retinoid cancer prevention mechanism [J].
Dragnev, KH ;
Freemantle, SJ ;
Spinella, MJ ;
Dmitrovsky, E .
CANCER PREVENTION: MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS, 2001, 952 :13-22
[7]   SYNERGISTIC ENHANCEMENT OF T-CELL RESPONSES AND INTERLEUKIN-1 RECEPTOR EXPRESSION BY INTERLEUKIN-1 AND HEPARIN OR DEXTRAN SULFATE [J].
DZIARSKI, R .
CELLULAR IMMUNOLOGY, 1992, 145 (01) :100-110
[8]   A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer [J].
Joyce, JA ;
Freeman, C ;
Meyer-Morse, N ;
Parish, CR ;
Hanahan, D .
ONCOGENE, 2005, 24 (25) :4037-4051
[9]   CDK2/4 regulate retinoic acid-induced G1 arrest in hepatocellular carcinoma cells [J].
Jung, HY ;
Park, SH ;
Do Yoo, Y ;
Kim, JS ;
Kim, YH .
HEPATOLOGY RESEARCH, 2005, 31 (03) :143-152
[10]   Apoptosis induced by retinoic acid in Hep 3B cells in vitro [J].
Kim, DG ;
Jo, BH ;
You, KR ;
Ahn, DS .
CANCER LETTERS, 1996, 107 (01) :149-159